secwatch.observer — SEC 8-K summary
======================================

Issuer:     DELCATH SYSTEMS, INC. (DCTH)
CIK:        0000872912
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001628280-26-012004
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Delcath reports FY2025 revenue $85.2M, net income $2.7M; guides FY2026 revenue ≥$100M
--------------------------------------------------------------------------------

- FY2025 total revenue $85.2M, up 129% YoY ($37.2M); HEPZATO revenue $78.8M, CHEMOSAT $6.4M.
- Full-year net income $2.7M vs net loss $26.4M in 2024; adjusted EBITDA $25.1M.
- Cash $91.0M, no debt; repurchased 628,572 shares for $6.0M.
- FY2026 guidance: total revenue at least $100M, HEPZATO volume growth ≥20%, gross margin 84-87%.
- 28 active centers; 140% procedure volume growth in 2025; publications including CHOPIN study.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/872912/000162828026012004/0001628280-26-012004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/872912/000162828026012004/dcth-20260226.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-012004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer